封面
市場調查報告書
商品編碼
1672103

全球近距離放射治療市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Brachytherapy Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: | 出版商: Value Market Research | 英文 107 Pages | 商品交期: 最快1-2個工作天內

價格

全球近距離放射治療市場規模預計將從 2024 年的 10.9 億美元成長到 2033 年的 21.2 億美元,在 2026 年至 2033 年的預測期內呈現 7.72% 的強勁年複合成長率(CAGR)。

受癌症發病率不斷上升和針對性治療方案需求的推動,近距離放射治療市場正在經歷顯著成長。近距離放射治療是一種將放射源直接放置在腫瘤內或附近的放射治療形式,與傳統的外部放射治療相比,它具有多種優勢,包括減少對周圍健康組織的暴露並提高治療精度。隨著醫療保健提供者尋求提高患者的治療效果並最大限度地減少副作用,近距離放射治療的採用預計會增加,從而使該市場實現強勁擴張。越來越多的臨床證據支持近距離放射治療對治療前列腺癌、乳癌和子宮頸癌等各種癌症的療效,這進一步推動了這一趨勢。

此外,近距離放射治療技術的進步正在推動市場創新。新的放射性同位素、改進的輸送系統和先進的成像技術的發展正在提高近距離放射治療程序的有效性和安全性。這些創新不僅改善了治療結果,而且有助於醫療保健提供者的工作流程更加簡化。隨著研究不斷探索近距離放射治療的新應用,例如與免疫療法和其他治療方式相結合,在改善患者護理和治療結果的推動下,市場可能會進一步擴大。

此外,對個人化醫療的日益重視正在塑造近距離放射治療的格局。隨著醫療保健提供者擴大尋求為個別患者量身定做治療方案,對靈活且適應性強的近距離放射治療解決方案的需求可能會增加。這一趨勢在晚期癌症治療中尤其重要,了解腫瘤的具體特徵可以顯著影響治療決策。隨著近距離放射治療市場不斷發展,技術進步、個人化治療方法和改善患者治療效果的關注的融合將在推動其未來成長方面發揮關鍵作用。

我們的報告經過精心製作,為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分,以確保徹底了解市場格局:

市場概覽:市場的詳細介紹,包括定義、分類和行業現狀概述。

市場動態:深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析:根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局:對主要市場參與者的全面評估,包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測:根據歷史資料和當前市場狀況,預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析:評估不同地理區域的市場表現,確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會:識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

目錄

第 1 章:前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:近距離放射治療產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按劑量類型進行的市場吸引力分析
    • 按產品進行市場吸引力分析
    • 市場吸引力分析:按應用
    • 市場吸引力分析:按地區

第4章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球近距離放射治療市場分析:按劑量類型

  • 按劑量類型概述
  • 按劑量類型進行的歷史和預測數據分析
  • 高劑量率 (HDR) 近距離放射治療
  • 低劑量率 (LDR) 近距離放射治療

第 6 章:全球近距離放射治療市場分析:依產品

  • 產品概覽
  • 按產品進行的歷史和預測數據分析
  • 種子
  • 塗抹器和後裝器
  • 電子近距離放射治療

第 7 章:全球近距離放射治療市場分析:按應用

  • 概述:按應用
  • 歷史和預測數據分析:按應用
  • 攝護腺癌
  • 婦科癌症
  • 乳癌
  • 其他

第 8 章:全球近距離放射治療市場分析:按地區分類

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第 9 章:近距離放射治療公司的競爭格局

  • 近距離放射治療市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他進展

第10章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Varian Medical Systems Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Becton
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Dickinson & Company
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Elekta AB
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Isoray Medical Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Eckert & Ziegler BEBIG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • ICAD Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • CIVCO Medical Solutions
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Theragenics Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中,財務細節和最新發展取決於可用性,對於私人公司,可能不予涵蓋

Product Code: VMR11211002

Global Brachytherapy Market size is anticipated to grow from USD 1.09 Billion in 2024 to USD 2.12 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.72% during the forecast period of 2026 to 2033.

The brachytherapy market is experiencing significant growth, driven by the increasing prevalence of cancer and the demand for targeted treatment options. Brachytherapy, a form of radiation therapy that involves placing radioactive sources directly within or near a tumor, offers several advantages over traditional external beam radiation therapy, including reduced exposure to surrounding healthy tissues and improved treatment precision. As healthcare providers seek to enhance patient outcomes and minimize side effects, the adoption of brachytherapy is expected to rise, positioning this market for robust expansion. The growing body of clinical evidence supporting the efficacy of brachytherapy in treating various cancers, including prostate, breast, and cervical cancers, is further fueling this trend.

Moreover, advancements in brachytherapy technologies are driving innovation within the market. The development of new radioactive isotopes, improved delivery systems, and advanced imaging techniques is enhancing the effectiveness and safety of brachytherapy procedures. These innovations not only improve treatment outcomes but also contribute to a more streamlined workflow for healthcare providers. As research continues to explore new applications for brachytherapy, such as in combination with immunotherapy and other treatment modalities, the market is likely to expand further, driven by the promise of improved patient care and outcomes.

Additionally, the growing emphasis on personalized medicine is shaping the brachytherapy landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable brachytherapy solutions is likely to rise. This trend is particularly relevant in the context of advanced cancer treatments, where understanding the specific characteristics of a tumor can significantly impact treatment decisions. As the brachytherapy market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Dosage Type

  • High-Dose Rate (HDR) Brachytherapy
  • Low-Dose Rate (LDR) Brachytherapy

By Product

  • Seeds
  • Applicators & Afterloaders
  • Electronic Brachytherapy

By Application

  • Prostate Cancer
  • Gynaecological Cancer
  • Breast Cancer
  • Others
  • COMPANIES PROFILED
  • Varian Medical Systems Inc.
  • Becton
  • Dickinson & Company
  • Elekta AB
  • Isoray Medical Inc.
  • Eckert & Ziegler BEBIG
  • iCAD Inc.
  • CIVCO Medical Solutions
  • Theragenics Corporation
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BRACHYTHERAPY INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Dosage Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY DOSAGE TYPE

  • 5.1. Overview By Dosage Type
  • 5.2. Historical and Forecast Data Analysis By Dosage Type
  • 5.3. High-Dose Rate (HDR) Brachytherapy Historic and Forecast Sales By Regions
  • 5.4. Low-Dose Rate (LDR) Brachytherapy Historic and Forecast Sales By Regions

6. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Seeds Historic and Forecast Sales By Regions
  • 6.4. Applicators & Afterloaders Historic and Forecast Sales By Regions
  • 6.5. Electronic Brachytherapy Historic and Forecast Sales By Regions

7. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Prostate Cancer Historic and Forecast Sales By Regions
  • 7.4. Gynaecological Cancer Historic and Forecast Sales By Regions
  • 7.5. Breast Cancer Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BRACHYTHERAPY COMPANIES

  • 9.1. Brachytherapy Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF BRACHYTHERAPY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Varian Medical Systems Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Becton
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Dickinson & Company
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Elekta AB
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Isoray Medical Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Eckert & Ziegler BEBIG
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. ICAD Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. CIVCO Medical Solutions
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Theragenics Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Dosage Type (USD MN)
  • High-Dose Rate (HDR) Brachytherapy Market Sales By Geography (USD MN)
  • Low-Dose Rate (LDR) Brachytherapy Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Seeds Market Sales By Geography (USD MN)
  • Applicators & Afterloaders Market Sales By Geography (USD MN)
  • Electronic Brachytherapy Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Gynaecological Cancer Market Sales By Geography (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Brachytherapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Brachytherapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Brachytherapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Dosage Type
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Dosage Type (USD MN)
  • High-Dose Rate (HDR) Brachytherapy Market Sales By Geography (USD MN)
  • Low-Dose Rate (LDR) Brachytherapy Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Seeds Market Sales By Geography (USD MN)
  • Applicators & Afterloaders Market Sales By Geography (USD MN)
  • Electronic Brachytherapy Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Gynaecological Cancer Market Sales By Geography (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.